他汀类药物抑制人类抗原呈递细胞功能：对移植物抗宿主病治疗的意义。 - Suppr

Suppr

超能文献

Statins inhibit human APC function: implications for the treatment of GVHD.

作者信息

Shimabukuro-Vornhagen Alexander, Liebig Tanja, von Bergwelt-Baildon Michael

出版信息

Blood. 2008 Aug 15;112(4):1544-5. doi: 10.1182/blood-2008-04-149609.

DOI:10.1182/blood-2008-04-149609

PMID:18684883

Abstract

摘要

相似文献

Statins inhibit human APC function: implications for the treatment of GVHD.

Blood. 2008 Aug 15;112(4):1544-5. doi: 10.1182/blood-2008-04-149609.

The use of statins in hematopoietic stem cell transplantation.

Curr Stem Cell Res Ther. 2009 Dec;4(4):260-5.

Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.

Leuk Lymphoma. 2013 Dec;54(12):2601-5. doi: 10.3109/10428194.2013.790022. Epub 2013 Jul 29.

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Nature. 2002 Nov 7;420(6911):78-84. doi: 10.1038/nature01158.

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

Transplant Proc. 1998 Jun;30(4):992-5. doi: 10.1016/s0041-1345(98)00123-7.

Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors.

Clin Immunol. 2006 Apr;119(1):1-12. doi: 10.1016/j.clim.2005.11.007. Epub 2006 Jan 4.

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.

Cardiovasc Res. 2003 Sep 1;59(3):755-66. doi: 10.1016/s0008-6363(03)00515-7.

Polyphenolic antioxidants inhibit peptide presentation by antigen-presenting cells.

Int Immunopharmacol. 2003 Dec;3(13-14):1841-52. doi: 10.1016/j.intimp.2003.08.010.

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1784-9. doi: 10.1161/01.atv.0000037098.20829.31.

Statins and their potential targets in multiple sclerosis therapy.

Expert Opin Ther Targets. 2003 Oct;7(5):613-22. doi: 10.1517/14728222.7.5.613.

引用本文的文献

Do Statins Affect Viral Infections Encountered by International Travelers?

Trop Med Infect Dis. 2025 Mar 11;10(3):73. doi: 10.3390/tropicalmed10030073.

Fluvastatin Promotes Treg Cell Production in Allogeneic Immune Reaction and Suppresses Inflammatory Response.

Immun Inflamm Dis. 2025 Feb;13(2):e70165. doi: 10.1002/iid3.70165.

Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Transplant Cell Ther. 2023 Nov;29(11):701.e1-701.e8. doi: 10.1016/j.jtct.2023.08.027. Epub 2023 Aug 30.

From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease.

Front Immunol. 2023 Jun 8;14:1192084. doi: 10.3389/fimmu.2023.1192084. eCollection 2023.

Effect of Statins on the Risk of Poststroke Pneumonia: National Population-Based Cohort Study.

Infect Drug Resist. 2020 Aug 6;13:2689-2698. doi: 10.2147/IDR.S258420. eCollection 2020.

Correlation of T Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease.

Int J Hematol Oncol Stem Cell Res. 2019 Oct 1;13(4):183-188.

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease.

Curr Pathobiol Rep. 2018;6(4):247-263. doi: 10.1007/s40139-018-0186-6. Epub 2018 Nov 19.

Immune modulatory effects of statins.

Immunology. 2018 May;154(1):69-75. doi: 10.1111/imm.12902. Epub 2018 Feb 20.

Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Regen Eng Transl Med. 2016 Mar;2(1):37-50. doi: 10.1007/s40883-016-0012-9. Epub 2016 Mar 3.

Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

Biol Blood Marrow Transplant. 2016 Jan;22(1):71-9. doi: 10.1016/j.bbmt.2015.07.034. Epub 2015 Aug 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验